Enliven Therapeutics, Inc (ELVN) Misses Q4 EPS by 47c

Enliven Therapeutics, Inc (NASDAQ: ELVN) reported Q4 EPS of ($0.47).

For earnings history and earnings-related data on Enliven Therapeutics, Inc (ELVN) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
• Yum! Brands (YUM) PT Lowered to $180 at Argus